Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ELYM

Eliem Therapeutics (ELYM)

Eliem Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ELYM
DateTimeSourceHeadlineSymbolCompany
05/15/20245:19AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELYMEliem Therapeutics Inc
05/07/20245:01PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ELYMEliem Therapeutics Inc
04/11/20243:27PMPR Newswire (US)Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to Contact Law FirmNASDAQ:ELYMEliem Therapeutics Inc
04/11/20246:00AMGlobeNewswire Inc.Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private PlacementNASDAQ:ELYMEliem Therapeutics Inc
03/04/202410:07AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELYMEliem Therapeutics Inc
11/14/20233:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELYMEliem Therapeutics Inc
11/13/20234:13PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ELYMEliem Therapeutics Inc
08/10/20233:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELYMEliem Therapeutics Inc
07/20/20235:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELYMEliem Therapeutics Inc
07/20/20235:45AMGlobeNewswire Inc.Eliem Therapeutics Announces Plans to Explore Strategic AlternativesNASDAQ:ELYMEliem Therapeutics Inc
05/22/20234:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ELYMEliem Therapeutics Inc
05/22/20234:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ELYMEliem Therapeutics Inc
05/19/20233:46PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ELYMEliem Therapeutics Inc
05/11/20233:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ELYMEliem Therapeutics Inc
05/11/20233:10PMGlobeNewswire Inc.Eliem Therapeutics Reports First Quarter Financial Results and Business HighlightsNASDAQ:ELYMEliem Therapeutics Inc
04/06/20233:17PMEdgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ELYMEliem Therapeutics Inc
04/06/20233:06PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ELYMEliem Therapeutics Inc
03/16/20233:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ELYMEliem Therapeutics Inc
03/14/20234:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ELYMEliem Therapeutics Inc
03/08/20233:01PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELYMEliem Therapeutics Inc
03/06/20233:53PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ELYMEliem Therapeutics Inc
03/06/20233:50PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ELYMEliem Therapeutics Inc
03/06/20233:10PMGlobeNewswire Inc.Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business HighlightsNASDAQ:ELYMEliem Therapeutics Inc
02/14/20231:23PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELYMEliem Therapeutics Inc
02/09/20233:01PMGlobeNewswire Inc.Eliem Therapeutics Provides Strategic Update and Announces Leadership TransitionNASDAQ:ELYMEliem Therapeutics Inc
02/08/20233:36PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELYMEliem Therapeutics Inc
12/20/20223:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ELYMEliem Therapeutics Inc
11/30/20226:00AMGlobeNewswire Inc.Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual ConferenceNASDAQ:ELYMEliem Therapeutics Inc
11/16/20221:55AMTipRanksSVB Securities Sticks to Their Buy Rating for Eliem Therapeutics (ELYM)NASDAQ:ELYMEliem Therapeutics Inc
11/15/20225:16AMTipRanksH.C. Wainwright Sticks to Their Buy Rating for Eliem Therapeutics (ELYM)NASDAQ:ELYMEliem Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ELYM